A brand new study has found that stem cell therapy is able to reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still in a pre-clinical stage, these findings have important potential ramifications for the future treatment of   patients.